"Hours may differ due to Coronavirus response."

During the past decade, Forbes Hospital conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 19 clinical trials were completed, i.e. on average, 37.3% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 16 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Forbes Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 28 trials, followed by "Alliance for Clinical Trials in Oncology" with 11 trials sponsored, "NRG Oncology" with 9 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored and "NSABP Foundation Inc" with 9 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Forbes Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 36 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Forbes Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Colorectal Cancer" (4 trials), "Recurrent Ovarian Carcinoma" (4 trials) and "Stage IIIA Breast Cancer" (4 trials). Many other conditions were trialed in "Forbes Hospital" in a lesser frequency.

Most popular intervention types in "Forbes Hospital" are "Drug" (52 trials), "Other" (48 trials), "Biological" (27 trials), "Procedure" (25 trials) and "Radiation" (18 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (24 trials), "Laboratory Biomarker Analysis" (22 trials), "Questionnaire Administration" (16 trials), "Computed Tomography" (14 trials) and "Paclitaxel" (12 trials). Other intervention names were less common.

The vast majority of trials in "Forbes Hospital" are 53 trials for "All" genders, 16 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Forbes Hospital". undefined are not yet recruiting, 20 are recruiting, 32 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Forbes Hospital, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Forbes Hospital, 0 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".